Vitamin A-Mediated Birth Defects : A Narrative Review
Copyright © 2023, Abadie et al..
Vitamin A deficiency (VAD) or excess in expectant mothers can result in fetal abnormalities such as night blindness, bone anomalies, or epithelial cell problems. In contrast, excessive vitamin A in pregnancy can precipitate fetal central nervous system deformities. During pregnancy, a pregnant woman should monitor her vitamin A intake ensuring she gets the recommended dosage, but also ensuring she doesn't exceed the recommended dosage, because either one can result in teratogenicity in the fetus. The widespread and unregulated use of multivitamins and supplements makes consuming doses greater than the recommended quantity more common in developed countries. While vitamin A excess is more common in developed countries, deficiency is most prevalent in developing countries. With proper maintenance, regulation, and education about VAD and excess, a pregnant mother can diminish potential harm to her fetus and potential teratogenic risks.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Cureus - 15(2023), 12 vom: 12. Dez., Seite e50513 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Abadie, Raegan B [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Birth defects |
|---|
| Anmerkungen: |
Date Revised 17.01.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.7759/cureus.50513 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367166720 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367166720 | ||
| 003 | DE-627 | ||
| 005 | 20240117232219.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240116s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.7759/cureus.50513 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1262.xml |
| 035 | |a (DE-627)NLM367166720 | ||
| 035 | |a (NLM)38226115 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Abadie, Raegan B |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Vitamin A-Mediated Birth Defects |b A Narrative Review |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 17.01.2024 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright © 2023, Abadie et al. | ||
| 520 | |a Vitamin A deficiency (VAD) or excess in expectant mothers can result in fetal abnormalities such as night blindness, bone anomalies, or epithelial cell problems. In contrast, excessive vitamin A in pregnancy can precipitate fetal central nervous system deformities. During pregnancy, a pregnant woman should monitor her vitamin A intake ensuring she gets the recommended dosage, but also ensuring she doesn't exceed the recommended dosage, because either one can result in teratogenicity in the fetus. The widespread and unregulated use of multivitamins and supplements makes consuming doses greater than the recommended quantity more common in developed countries. While vitamin A excess is more common in developed countries, deficiency is most prevalent in developing countries. With proper maintenance, regulation, and education about VAD and excess, a pregnant mother can diminish potential harm to her fetus and potential teratogenic risks | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a birth defects | |
| 650 | 4 | |a current recommendations | |
| 650 | 4 | |a excess | |
| 650 | 4 | |a pregnant intake | |
| 650 | 4 | |a provitamin | |
| 650 | 4 | |a teratogenicity | |
| 650 | 4 | |a vitamin a | |
| 700 | 1 | |a Staples, Abigail A |e verfasserin |4 aut | |
| 700 | 1 | |a Lauck, Lillian V |e verfasserin |4 aut | |
| 700 | 1 | |a Dautel, Alexandra D |e verfasserin |4 aut | |
| 700 | 1 | |a Spillers, Noah J |e verfasserin |4 aut | |
| 700 | 1 | |a Klapper, Rachel J |e verfasserin |4 aut | |
| 700 | 1 | |a Hirsch, Jon D |e verfasserin |4 aut | |
| 700 | 1 | |a Varrassi, Giustino |e verfasserin |4 aut | |
| 700 | 1 | |a Ahmadzadeh, Shahab |e verfasserin |4 aut | |
| 700 | 1 | |a Shekoohi, Sahar |e verfasserin |4 aut | |
| 700 | 1 | |a Kaye, Alan D |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cureus |d 2013 |g 15(2023), 12 vom: 12. Dez., Seite e50513 |w (DE-627)NLM24118083X |x 2168-8184 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2023 |g number:12 |g day:12 |g month:12 |g pages:e50513 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.7759/cureus.50513 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2023 |e 12 |b 12 |c 12 |h e50513 | ||